NSC 676914 has been identified as a novel, specific and stable small-molecular NF-κB inhibitor through the inhibition of IKK-β to induce growth inhibition of multiple myeloma cells in vitro and in vivo [19,26]. This evidence concerns the gene NFKB1 and plasma cell myeloma.